Opportunities to Reform the Food and Drug Administration’s Center for Tobacco Products
New leadership at the FDA will have the opportunity to revisit decisions that have shifted consumption to illicit products and discouraged harm reduction—policies that, however well intended, have come at a significant cost in lives.
7 min read